HELE vs LWAY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HELE exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 2/9, indicating weak fundamental health. While valuation metrics like Price/Book (0.45) and Forward P/E (4.99) suggest the stock is undervalued, these are likely 'value traps' given the catastrophic 5-year price decline of 92.3% and a deeply negative ROE of -63.90%. The combination of shrinking revenue, negative profit margins, and a bearish technical trend suggests a company in a structural decline rather than a temporary dip.
LWAY exhibits a weak Piotroski F-Score of 3/9, indicating deteriorating fundamental health despite a clean balance sheet. The stock is trading at a severe premium to both its Graham Number ($10.62) and Intrinsic Value ($6.23), suggesting the current price of $24.40 is speculative. While revenue growth is strong at 18%, consistent earnings misses and aggressive insider selling signal a lack of confidence in the current valuation.
Compare Another Pair
Related Comparisons
HELE vs LWAY: Head-to-Head Comparison
This page compares Helen of Troy Limited (HELE) and Lifeway Foods, Inc. (LWAY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.